Archive

02 August 2019, Volume 35 Issue 8 Previous Issue    Next Issue

---

For Selected:

Download Citations EndNote Ris BibTeX

Toggle Thumbnails

Select

Classification of uterine fibroids and strategy of clinical treatment. ZHANG Hui-ying，XUE Feng-xia 2019, 35(8): 857-860.  DOI: 10.19538/j.fk2019080103 Abstract ( )   Uterine fibroid is a common gynecological disease，patients with which would present no symptoms or severe symptoms based on the location and size of focus.According to their relationship with uterine cavity and serosa，uterine fibroids can be classified into several types.In clinical practice，different measures should be taken depending on the type and size of fibroids as well as the age，fertility desire，reproductive function and symptoms of patients.This paper elaborates the classification of uterine fibroids and corresponding strategy of clinical treatments.

Select

Preoperative differential diagnosis of uterine sarcoma and uterine myoma. ZHANG Lu-fang，CAI Jing 2019, 35(8): 861-864.  DOI: 10.19538/j.fk2019080104 Abstract ( )   Uterine sarcoma is a rare uterine malignant tumor characterized by extremely aggressive behavior with a high recurrence rate and poor prognosis. It remains very challenging to distinguish uterine sarcomas from uterine fibroids prior to surgery because of the similar clinical manifestations and the lack of specific imaging features and tumor markers. An integrated analysis algorism including risk factors，symptoms，imaging analysis（pelvic ultrasound and MRI），and endometrial biopsy is helpful for the preoperative differential diagnosis between uterine sarcomas and uterine leiomyomas.

Select

Uterine leiomyoma and related issues of fertility and pregnancy safety. ZHANG Dan-dan，LU Mei-song 2019, 35(8): 864-868.  DOI: 10.19538/j.fk2019080105 Abstract ( )   Uterine leiomyoma is a common benign tumour in women of childbearing age，with an incidence of 25%-30%.Uterine myoma can cause infertility，as well as abortion，premature delivery，placental abruption and postpartum hemorrhage and other adverse pregnancy outcomes，which increases the cesarean section rate.The influence of uterine leiomyoma on fertility is closely related to its location and size.The treatment should be individualized，considering the size，location and fertility of the myoma.

Select

Detection of occult fibroids in myomectomy. LIU Chong-dong，DENG Yu-peng 2019, 35(8): 869-872.  DOI: 10.19538/j.fk2019080106 Abstract ( )   Uterine fibroids（leiomyomas or myomas）are extremely common benign neoplasms of the uterus.Myomectomy is a conservative surgical method，including laparotomy，laparoscopy and vaginal surgery and so on.The uterine-sparing intervention may lead to recurrence after surgery.The purpose of this manuscript is to discuss how to detect occult fibroids in myomectomy so as to improve the treatment effect of myomectomy and reduce the risk of recurrence.

Select

Non-surgical management of uterine myoma. LI Hu，HU Li-na 2019, 35(8): 872-877.  DOI: 10.19538/j.fk2019080107 Abstract ( )   Uterine fibroids are benign diseases with high incidence and unknown pathogenesis.Currently，fibroid excavation or hysterectomy is the most commonly used treatment，but for women who require conservative treatment or with fertility requirements，there is still no optimal treatment option.At present，GnRH agonists/antagonists，selective progesterone receptor antagonists，levonorgestrel sustained release，uterine artery embolization，high-intensity focused ultrasound and other non-traditional surgical treatments provide new treatment options for conservative treatment of uterine fibroids from different angles.

Select

Recurrence of uterine fibroids. SONG Hui-juan，LIU Yi-bin 2019, 35(8): 877-879.  DOI: 10.19538/j.fk2019080108 Abstract ( )   Recurrence of uterine fibroids after myomectomy is common，and the mechanism of recurrence is unknown.The recurrence rate may be related to the number，size and type of fibroids.The treatment for recurrent uterine fibroids is the same as that for primary fibroids.Currently，there is no effective method or drug to prevent recurrence.The risk of recurrence should be assessed at the same time with surgery，and postoperative guidance and follow-up should be done.